Guardant Health Inc (GH) Company Profile & Statistics

Guardant Health Inc
GH
(Nasdaq - US)
Closed
30.98
+0.30 (+0.98%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
30.85
High
31.15
Low
30.32

About Guardant Health Inc

CEO

Helmy Eltoukhy

Headquarters

3100 hanover street

palo alto, ca 94304, united states

Auditor

Deloitte & Touche LLP

Employees

1,779

Share Holders

Website

www.guardanthealth.com

Industry

medical or nursing services

Sector

health services

Company Overview

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.

Guardant Health Inc Statistics

Valuation Measures

Market Capitalization ²	3.83B
Enterprise Value	4.28B
Enterprise Value/EBITDA (ttm)	-9.01
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	5.48
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	60.29%
Operating Margin (ttm)	-71.64%
Profit Margin (ttm)	-75.76%
Return on Equity (ttm)	-1200.44%
Return on Invested Capital (ttm)	-42.88%
Return on Assets (ttm)	-29.88%

Income Statement

Revenue (ttm)	692.26M
Revenue Per Share (ttm)	5.60
Gross Profit (ttm)	417.53M
EBITDA (ttm)³	-475.21M
Net Income Avi to Common (ttm)	-512.41M
Diluted EPS (ttm)	-4.24

Share Statistics

Beta (5Y Monthly)	1.11
52-Week Change	29.62%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	123.55M
Dividend Yield	0.00%
Float ⁴	116.76M
% Held by Insiders	5.50%
% Held by Institutions	92.60%

Balance Sheet

Total Cash (mrq)	999.07M
Total Cash Per Share (mrq)	8.09
Total Debt (mrq)	1.14B
Total Debt/Equity (mrq)	-1900.13%
Current Ratio (mrq)	6.22%
Quick Ratio (mrq)	5.85%
Book Value Per Share (mrq)	-0.49

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.43
Free Cash Flow (ytd)	-191.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Guardant Health Inc

Trade With A Regulated Broker